Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Prostate Cancer Patients × carbon-11 acetate × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 3 Tuberous Sclerosis 1 Recurrence 1 Prostate Cancer Patients 1 Neoplasms 1 Lymphangioleiomyomatosis 1 Glioma 1 Glioblastoma 1 Carcinoma, Hepatocellular 1 Brain Neoplasms 1

Interventions

repaglinide 1 carbon-11 acetate 1 Interviews as Topic 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02715583 2022-05-18

C-Acetate PET/CT Imaging to Evaluate Treatment Changes in Prostate Cancer

Abramson Cancer Center at Penn Medicine

Phase EARLY_PHASE1 Completed

Prostate Cancer Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡